Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) EBITDA Margin (2022 - 2023)

Historic EBITDA Margin for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to 3200.75%.

  • Bluejay Diagnostics' EBITDA Margin fell 24034000.0% to 3200.75% in Q2 2023 from the same period last year, while for Jun 2023 it was 4706.94%, marking a year-over-year change of. This contributed to the annual value of 887.55% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Bluejay Diagnostics reported EBITDA Margin of 3200.75% as of Q2 2023, which was down 24034000.0% from 1917.69% recorded in Q1 2023.
  • Bluejay Diagnostics' 5-year EBITDA Margin high stood at 797.35% for Q2 2022, and its period low was 3770.21% during Q1 2022.